In turn, it was demonstrated, that metformin inhibited HIF1A and suppressed the expression of glucose transporters (GLUT1, GLUT3) and regulatory enzymes of the glycolytic pathway in cervical tumor cells [28]. Here, SLC2A3 is linked to uterine cervix neoplasm.